메뉴 건너뛰기




Volumn 26, Issue , 2016, Pages

Recent developments in the diagnosis and management of tuberculosis

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

EID: 84994336806     PISSN: None     EISSN: 20551010     Source Type: Journal    
DOI: 10.1038/npjpcrm.2016.78     Document Type: Article
Times cited : (58)

References (100)
  • 1
    • 84893257773 scopus 로고    scopus 로고
    • (World Health Organization)
    • World Health Organization. Global Tuberculosis Report (World Health Organization, 2015).
    • (2015) Global Tuberculosis Report
  • 2
    • 84867115232 scopus 로고    scopus 로고
    • Social determinants of tuberculosis in Europe: A prospective ecological study
    • Ploubidis, G. B. et al. Social determinants of tuberculosis in Europe: a prospective ecological study. Eur. Respir. J. 40, 925-930 (2012).
    • (2012) Eur. Respir. J. , vol.40 , pp. 925-930
    • Ploubidis, G.B.1
  • 3
    • 84905397869 scopus 로고    scopus 로고
    • Individual and social vulnerabilities upon acquiring tuberculosis: A literature systematic review
    • Nadjane Batista Lacerda, S. et al. Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int. Arch. Med. 7, 35-35 (2014).
    • (2014) Int. Arch. Med. , vol.7 , pp. 35
    • Nadjane Batista-Lacerda, S.1
  • 5
    • 84947037645 scopus 로고    scopus 로고
    • Causes of hospital admission among people living with HIV worldwide: A systematic review and meta-analysis
    • Ford, N. et al. Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis. Lancet HIV 2, e438-e444 (2015).
    • (2015) Lancet HIV , vol.2 , pp. e438-e444
    • Ford, N.1
  • 6
    • 80053084687 scopus 로고    scopus 로고
    • The burden of TB-HIV in the EU: How much do we know? A survey of surveillance practices and results
    • Kruijshaar, M. E. et al. The burden of TB-HIV in the EU: how much do we know? A survey of surveillance practices and results. Eur. Respir. J. 38, 1374-1381 (2011).
    • (2011) Eur. Respir. J. , vol.38 , pp. 1374-1381
    • Kruijshaar, M.E.1
  • 7
    • 84906046594 scopus 로고    scopus 로고
    • Delivering TB/HIV services in Ghana: A comparative study of service delivery models
    • Ansa, G. A., Walley, J. D., Siddiqi, K. & Wei, X. Delivering TB/HIV services in Ghana: a comparative study of service delivery models. Trans. R. Soc. Trop. Med. Hyg. 108, 560-567 (2014).
    • (2014) Trans. R. Soc. Trop. Med. Hyg. , vol.108 , pp. 560-567
    • Ansa, G.A.1    Walley, J.D.2    Siddiqi, K.3    Wei, X.4
  • 8
    • 84891619248 scopus 로고    scopus 로고
    • Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa
    • Uyei, J., Coetzee, D., Macinko, J., Weinberg, S. L. & Guttmacher, S. Measuring the degree of integrated tuberculosis and HIV service delivery in Cape Town, South Africa. Health Policy Plan. 29, 42-55 (2014).
    • (2014) Health Policy Plan. , vol.29 , pp. 42-55
    • Uyei, J.1    Coetzee, D.2    Macinko, J.3    Weinberg, S.L.4    Guttmacher, S.5
  • 9
    • 84866078656 scopus 로고    scopus 로고
    • PEPFAR support for the scaling up of collaborative TB/HIV activities
    • Howard, A. A. et al. PEPFAR support for the scaling up of collaborative TB/HIV activities. J. Acquir. Immune Defic. Syndr. 60(Suppl 3): S136-S144 (2012).
    • (2012) J. Acquir. Immune Defic. Syndr. , vol.60 , pp. S136-S144
    • Howard, A.A.1
  • 10
    • 84901488729 scopus 로고    scopus 로고
    • Scaling up intensified tuberculosis case finding in HIV clinics in Rwanda
    • Uwinkindi, F. et al. Scaling up intensified tuberculosis case finding in HIV clinics in Rwanda. J. Acquir. Immune Defic. Syndr. 66, e45-e49 (2014).
    • (2014) J. Acquir. Immune Defic. Syndr. , vol.66 , pp. e45-e49
    • Uwinkindi, F.1
  • 11
    • 84872698280 scopus 로고    scopus 로고
    • Integrating tuberculosis and HIV services in low- and middle-income countries: A systematic review
    • Legido-Quigley, H. et al. Integrating tuberculosis and HIV services in low- and middle-income countries: a systematic review. Trop. Med. Int. Health 18, 199-211 (2013).
    • (2013) Trop. Med. Int. Health , vol.18 , pp. 199-211
    • Legido-Quigley, H.1
  • 12
    • 79955657437 scopus 로고    scopus 로고
    • Tuberculosis and noncommunicable diseases: Neglected links and missed opportunities
    • Creswell, J. et al. Tuberculosis and noncommunicable diseases: neglected links and missed opportunities. Eur. Respir. J. 37, 1269-1282 (2011).
    • (2011) Eur. Respir. J. , vol.37 , pp. 1269-1282
    • Creswell, J.1
  • 13
    • 84859215760 scopus 로고    scopus 로고
    • Risk factors associated with pulmonary tuberculosis: Smoking, diabetes and anti-TNFalpha drugs
    • Ferrara, G. et al. Risk factors associated with pulmonary tuberculosis: smoking, diabetes and anti-TNFalpha drugs. Curr. Opin. Pulm. Med. 18, 233-240 (2012).
    • (2012) Curr. Opin. Pulm. Med. , vol.18 , pp. 233-240
    • Ferrara, G.1
  • 16
    • 84920584733 scopus 로고    scopus 로고
    • Multidrug-resistant tuberculosis around the world: What progress has been made?
    • Falzon, D. et al. Multidrug-resistant tuberculosis around the world: what progress has been made? Eur. Respir. J. 45, 150-160 (2015).
    • (2015) Eur. Respir. J. , vol.45 , pp. 150-160
    • Falzon, D.1
  • 17
    • 84943541115 scopus 로고    scopus 로고
    • Shifting to sustainable development goals-implications for global health
    • Murray, C. J. L. Shifting to sustainable development goals-implications for global health. N. Engl. J. Med. 373, 1390-1393 (2015).
    • (2015) N. Engl. J. Med. , vol.373 , pp. 1390-1393
    • Murray, C.J.L.1
  • 18
    • 84949498536 scopus 로고    scopus 로고
    • Stopping tuberculosis: A biosocial model for sustainable development
    • Ortblad, K. F., Salomon, J. A., Barnighausen, T. & Atun, R. Stopping tuberculosis: a biosocial model for sustainable development. Lancet 386, 2354-2362 (2015).
    • (2015) Lancet , vol.386 , pp. 2354-2362
    • Ortblad, K.F.1    Salomon, J.A.2    Barnighausen, T.3    Atun, R.4
  • 19
    • 84929032442 scopus 로고    scopus 로고
    • WHO's new end TB strategy
    • Uplekar, M. et al. WHO's new end TB strategy. Lancet 385, 1799-1801 (2015).
    • (2015) Lancet , vol.385 , pp. 1799-1801
    • Uplekar, M.1
  • 20
    • 60449119706 scopus 로고    scopus 로고
    • Reflections on the white plague
    • Zumla, A. et al. Reflections on the white plague. Lancet Infect. Dis. 9, 197-202 (2009).
    • (2009) Lancet Infect. Dis. , vol.9 , pp. 197-202
    • Zumla, A.1
  • 21
    • 0003878012 scopus 로고
    • (World Health Organization)
    • World Health Organization. TB: a Global Emergency, WHO Report on the TB Epidemic. (World Health Organization, 1994). Available at http://apps.who.int/iris/handle/10665/58749#sthash.trpE3VaC.dpuf.
    • (1994) TB: A Global Emergency, WHO Report on the TB Epidemic
  • 23
    • 20144370344 scopus 로고    scopus 로고
    • Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally
    • Dye, C., Watt, C. J., Bleed, D. M., Hosseini, S. M. & Raviglione, M. C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA 293, 2767-2775 (2005).
    • (2005) JAMA , vol.293 , pp. 2767-2775
    • Dye, C.1    Watt, C.J.2    Bleed, D.M.3    Hosseini, S.M.4    Raviglione, M.C.5
  • 24
    • 33645016204 scopus 로고    scopus 로고
    • WHO's new stop TB strategy
    • Raviglione, M. C. & Uplekar, M. W. WHO's new Stop TB Strategy. Lancet 367, 952-955 (2006).
    • (2006) Lancet , vol.367 , pp. 952-955
    • Raviglione, M.C.1    Uplekar, M.W.2
  • 25
    • 84943428817 scopus 로고    scopus 로고
    • Translating the tuberculosis research agenda: Much accomplished, but much more to be done
    • Schito, M., Maeurer, M., Kim, P., Hanna, D. & Zumla, A. Translating the Tuberculosis Research Agenda: much accomplished, but much more to be done. Clin. Infect. Dis. 61, S95-S101 (2015).
    • (2015) Clin. Infect. Dis. , vol.61 , pp. S95-S101
    • Schito, M.1    Maeurer, M.2    Kim, P.3    Hanna, D.4    Zumla, A.5
  • 26
    • 84922970030 scopus 로고    scopus 로고
    • Towards tuberculosis elimination: An action framework for low-incidence countries
    • Lönnroth, K. et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur. Respir. J. 45, 928-952 (2015).
    • (2015) Eur. Respir. J. , vol.45 , pp. 928-952
    • Lönnroth, K.1
  • 27
    • 84880142045 scopus 로고    scopus 로고
    • Old ideas to innovate tuberculosis control: Preventive treatment to achieve elimination
    • Diel, R. et al. Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur. Respir. J. 42, 785-801 (2013).
    • (2013) Eur. Respir. J. , vol.42 , pp. 785-801
    • Diel, R.1
  • 28
    • 84896477367 scopus 로고    scopus 로고
    • Tuberculosis elimination: Theory and practice in Europe
    • D'Ambrosio, L. et al. Tuberculosis elimination: theory and practice in Europe. Eur. Respir. J. 43, 1410-1420 (2014).
    • (2014) Eur. Respir. J. , vol.43 , pp. 1410-1420
    • D'Ambrosio, L.1
  • 29
    • 84949035058 scopus 로고    scopus 로고
    • Management of latent mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries
    • Getahun, H. et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur. Respir. J. 46, 1563-1576 (2015).
    • (2015) Eur. Respir. J. , vol.46 , pp. 1563-1576
    • Getahun, H.1
  • 30
    • 84860337632 scopus 로고    scopus 로고
    • European union standards for tuberculosis care
    • Migliori, G. B. et al. European union standards for tuberculosis care. Eur. Respir. J. 39, 807-819 (2012).
    • (2012) Eur. Respir. J. , vol.39 , pp. 807-819
    • Migliori, G.B.1
  • 31
  • 33
    • 46349101177 scopus 로고    scopus 로고
    • Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum
    • Marais, B. J. et al. Use of light-emitting diode fluorescence microscopy to detect acid-fast bacilli in sputum. Clin. Infect. Dis. 47, 203-207 (2008).
    • (2008) Clin. Infect. Dis. , vol.47 , pp. 203-207
    • Marais, B.J.1
  • 36
    • 84956698324 scopus 로고    scopus 로고
    • Implementing the xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: Outcomes and lessons learned in 18 countries
    • Ardizzoni, E. et al. Implementing the Xpert(R) MTB/RIF diagnostic test for tuberculosis and rifampicin resistance: outcomes and lessons learned in 18 countries. PLoS ONE 10, e0144656 (2015).
    • (2015) PLoS ONE , vol.10 , pp. e0144656
    • Ardizzoni, E.1
  • 37
    • 84862205633 scopus 로고    scopus 로고
    • Clinical validation of xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
    • Tortoli, E. et al. Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis. Eur. Respir. J. 40, 442-447 (2012).
    • (2012) Eur. Respir. J. , vol.40 , pp. 442-447
    • Tortoli, E.1
  • 38
    • 84880151052 scopus 로고    scopus 로고
    • Rapid molecular TB diagnosis: Evidence, policy making and global implementation of xpert MTB/RIF
    • Weyer, K. et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur. Respir. J. 42, 252-271 (2013).
    • (2013) Eur. Respir. J. , vol.42 , pp. 252-271
    • Weyer, K.1
  • 39
    • 84925248470 scopus 로고    scopus 로고
    • Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
    • Steingart, K. R. et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst. Rev. 1, CD009593 (2014).
    • (2014) Cochrane Database Syst. Rev. , vol.1 , pp. CD009593
    • Steingart, K.R.1
  • 40
    • 84938100016 scopus 로고    scopus 로고
    • A novel solid medium for culturing mycobacterium tuberculosis isolates from clinical specimens
    • Asmar, S. et al. A novel solid medium for culturing mycobacterium tuberculosis isolates from clinical specimens. J. Clin. Microbiol. 53, 2566-2569 (2015).
    • (2015) J. Clin. Microbiol. , vol.53 , pp. 2566-2569
    • Asmar, S.1
  • 41
    • 48749127726 scopus 로고    scopus 로고
    • Geno type MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A meta-analysis
    • Ling, D. I., Zwerling, A. A. & Pai, M. Geno Type MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32, 1165-1174 (2008).
    • (2008) Eur. Respir. J. , vol.32 , pp. 1165-1174
    • Ling, D.I.1    Zwerling, A.A.2    Pai, M.3
  • 42
    • 84940054531 scopus 로고    scopus 로고
    • Diagnostic performance of the new version (v2.0) of geno type MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: A multicenter study
    • Tagliani, E. et al. Diagnostic performance of the new version (v2.0) of Geno Type MTBDRsl assay for detection of resistance to fluoroquinolones and second-line injectable drugs: a multicenter study. J. Clin. Microbiol. 53, 2961-2969 (2015).
    • (2015) J. Clin. Microbiol. , vol.53 , pp. 2961-2969
    • Tagliani, E.1
  • 44
    • 84942192606 scopus 로고    scopus 로고
    • Whole-genome sequencing for prediction of mycobacterium tuberculosis drug susceptibility and resistance: A retrospective cohort study
    • Walker, T. M. et al. Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study. Lancet Infect. Dis. 15, 1193-1202 (2015).
    • (2015) Lancet Infect. Dis. , vol.15 , pp. 1193-1202
    • Walker, T.M.1
  • 45
    • 84929994231 scopus 로고    scopus 로고
    • Defining the needs for next generation assays for tuberculosis
    • Denkinger, C. M. et al. Defining the needs for next generation assays for tuberculosis. J. Infect. Dis. 211(Suppl 2): S29-S38 (2015).
    • (2015) J. Infect. Dis. , vol.211 , pp. S29-S38
    • Denkinger, C.M.1
  • 46
    • 84959112161 scopus 로고    scopus 로고
    • Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe
    • Zijenah, L. S. et al. Comparative performance characteristics of the urine lipoarabinomannan strip test and sputum smear microscopy in hospitalized HIV-infected patients with suspected tuberculosis in Harare, Zimbabwe. BMC Infect. Dis. 16, 20 (2016).
    • (2016) BMC Infect. Dis. , vol.16 , pp. 20
    • Zijenah, L.S.1
  • 47
    • 84942811235 scopus 로고    scopus 로고
    • Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania
    • Kroidl, I. et al. Performance of urine lipoarabinomannan assays for paediatric tuberculosis in Tanzania. Eur. Respir. J. 46, 761-770 (2015).
    • (2015) Eur. Respir. J. , vol.46 , pp. 761-770
    • Kroidl, I.1
  • 48
    • 84922395137 scopus 로고    scopus 로고
    • Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults
    • Nakiyingi, L. et al. Diagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adults. J. Acquir. Immune Defic. Syndr. 66, 270-279 (2014).
    • (2014) J. Acquir. Immune Defic. Syndr. , vol.66 , pp. 270-279
    • Nakiyingi, L.1
  • 50
    • 84862003214 scopus 로고    scopus 로고
    • Point-of-care breath test for biomarkers of active pulmonary tuberculosis
    • Phillips, M. et al. Point-of-care breath test for biomarkers of active pulmonary tuberculosis. Tuberculosis 92, 314-320 (2012).
    • (2012) Tuberculosis , vol.92 , pp. 314-320
    • Phillips, M.1
  • 51
  • 53
    • 84880162469 scopus 로고    scopus 로고
    • Resistance to fluoroquinolones and second-line injectable drugs: Impact on multidrug-resistant TB outcomes
    • Falzon, D. et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur. Respir. J. 42, 56-168 (2013).
    • (2013) Eur. Respir. J. , vol.42 , pp. 56-168
    • Falzon, D.1
  • 54
    • 84880158505 scopus 로고    scopus 로고
    • Drug resistance beyond extensively drug-resistant tuberculosis: Individual patient data meta-analysis
    • Migliori, G. B. et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur. Respir. J. 42, 169-179 (2013).
    • (2013) Eur. Respir. J. , vol.42 , pp. 169-179
    • Migliori, G.B.1
  • 56
    • 84943258775 scopus 로고    scopus 로고
    • Classification of antituberculosis drugs: A new proposal based on the most recent evidence
    • Caminero, J. A. & Scardigli, A. Classification of antituberculosis drugs: a new proposal based on the most recent evidence. Eur. Respir. J. 46, 887-893 (2015).
    • (2015) Eur. Respir. J. , vol.46 , pp. 887-893
    • Caminero, J.A.1    Scardigli, A.2
  • 57
    • 85015466776 scopus 로고    scopus 로고
    • Short-course treatment for multidrug-resistant tuberculosis: The STREAM trials
    • Moodley, R. & Godec, T. R. Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials. Eur. Respir. Rev. 25, 29-35 (2016).
    • (2016) Eur. Respir. Rev. , vol.25 , pp. 29-35
    • Moodley, R.1    Godec, T.R.2
  • 58
    • 84928888056 scopus 로고    scopus 로고
    • High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon
    • Kuaban, C. et al. High effectiveness of a 12-month regimen for MDR-TB patients in Cameroon. Int. J. Tuberc. Lung Dis. 19, 517-524 (2015).
    • (2015) Int. J. Tuberc. Lung Dis. , vol.19 , pp. 517-524
    • Kuaban, C.1
  • 59
    • 84907033159 scopus 로고    scopus 로고
    • High cure rate with standardised short-course multidrugresistant tuberculosis treatment in Niger: No relapses
    • Piubello, A. et al. High cure rate with standardised short-course multidrugresistant tuberculosis treatment in Niger: no relapses. Int. J. Tuberc. Lung Dis. 18, 1188-1194 (2014).
    • (2014) Int. J. Tuberc. Lung Dis. , vol.18 , pp. 1188-1194
    • Piubello, A.1
  • 61
    • 84893513006 scopus 로고    scopus 로고
    • Costs of tuberculosis disease in the european union: A systematic analysis and cost calculation
    • Diel, R. et al. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation. Eur. Respir. J. 43, 554-565 (2014).
    • (2014) Eur. Respir. J. , vol.43 , pp. 554-565
    • Diel, R.1
  • 62
    • 84975042205 scopus 로고    scopus 로고
    • WHO recommendations on shorter treatment of multidrugresistant tuberculosis
    • Sotgiu, G. et al. WHO recommendations on shorter treatment of multidrugresistant tuberculosis. Lancet 387, 2486-2487 (2016).
    • (2016) Lancet , vol.387 , pp. 2486-2487
    • Sotgiu, G.1
  • 64
    • 84958093367 scopus 로고    scopus 로고
    • Bedaquiline and multidrug-resistant tuberculosis: A systematic and critical analysis of the evidence
    • Pontali, E., Sotgiu, G., D'Ambrosio, L., Centis, R. & Migliori, G. B. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence. Eur. Respir. J. 47, 394-402 (2016).
    • (2016) Eur. Respir. J. , vol.47 , pp. 394-402
    • Pontali, E.1    Sotgiu, G.2    D'Ambrosio, L.3    Centis, R.4    Migliori, G.B.5
  • 65
    • 84958073475 scopus 로고    scopus 로고
    • Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis
    • Pym, A. S. et al. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur. Respir. J. 47, 564-574 (2016).
    • (2016) Eur. Respir. J. , vol.47 , pp. 564-574
    • Pym, A.S.1
  • 69
    • 84964054940 scopus 로고    scopus 로고
    • Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB
    • Tiberi, S. et al. Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB. Eur. Respir. J. 47, 1235-1243 (2016).
    • (2016) Eur. Respir. J. , vol.47 , pp. 1235-1243
    • Tiberi, S.1
  • 70
    • 84966692560 scopus 로고    scopus 로고
    • Effectiveness and safety of imipenem-clavulanate added to an optimized background regimen (OBR) versus obr control regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis
    • Tiberi, S. et al. Effectiveness and safety of imipenem-clavulanate added to an optimized background regimen (OBR) versus obr control regimens in the treatment of multidrug-resistant and extensively drug-resistant tuberculosis. Clin. Infect. Dis. 62, 1188-1190 (2016).
    • (2016) Clin. Infect. Dis. , vol.62 , pp. 1188-1190
    • Tiberi, S.1
  • 71
    • 84973466840 scopus 로고    scopus 로고
    • Comparison of effectiveness and safety of imipenem/clavulanateversus meropenem/clavulanate-containing regimens in the treatment of MDRand XDR-TB
    • Tiberi, S. et al. Comparison of effectiveness and safety of imipenem/clavulanateversus meropenem/clavulanate-containing regimens in the treatment of MDRand XDR-TB. Eur. Respir. J. 47, 1758-1766 (2016).
    • (2016) Eur. Respir. J. , vol.47 , pp. 1758-1766
    • Tiberi, S.1
  • 72
    • 84954287886 scopus 로고    scopus 로고
    • Ertapenem in the treatment of multidrug-resistant tuberculosis: First clinical experience
    • Tiberi, S. et al. Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience. Eur. Respir. J. 47, 333-336 (2016).
    • (2016) Eur. Respir. J. , vol.47 , pp. 333-336
    • Tiberi, S.1
  • 73
    • 84920583395 scopus 로고    scopus 로고
    • Linezolid to treat MDR-/XDR-tuberculosis: Available evidence and future scenarios
    • Sotgiu, G., Pontali, E. & Migliori, G. B. Linezolid to treat MDR-/XDR-tuberculosis: available evidence and future scenarios. Eur. Respir. J. 45, 25-29 (2015).
    • (2015) Eur. Respir. J. , vol.45 , pp. 25-29
    • Sotgiu, G.1    Pontali, E.2    Migliori, G.B.3
  • 74
    • 84986182673 scopus 로고    scopus 로고
    • Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively-drug resistant tuberculosis: Early experiences and challenges
    • Tadolini, M. et al. Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively-drug resistant tuberculosis: early experiences and challenges. Eur. Respir. J. 48, 938-943 (2016).
    • (2016) Eur. Respir. J. , vol.48 , pp. 938-943
    • Tadolini, M.1
  • 75
    • 84906890048 scopus 로고    scopus 로고
    • ERS/WHO tuberculosis consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use
    • Esposito, S. et al. ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: Case study of compassionate delamanid use. Eur. Respir. J. 44, 811-815 (2014).
    • (2014) Eur. Respir. J. , vol.44 , pp. 811-815
    • Esposito, S.1
  • 76
    • 84956964941 scopus 로고    scopus 로고
    • Recommendations for treating children with drug-resistant tuberculosis
    • Galli, L. et al. Recommendations for treating children with drug-resistant tuberculosis. Pharmacol. Res. 105, 176-182 (2016).
    • (2016) Pharmacol. Res. , vol.105 , pp. 176-182
    • Galli, L.1
  • 77
    • 84986226612 scopus 로고    scopus 로고
    • First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
    • in press
    • Tadolini, M. et al. First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline. Eur. Respir. J. 48, 935-938, in press (2016).
    • (2016) Eur. Respir. J. , vol.48 , pp. 935-938
    • Tadolini, M.1
  • 78
    • 84959241751 scopus 로고    scopus 로고
    • Bedaquiline plus delamanid for XDR tuberculosis
    • Lachâtre, M. et al. Bedaquiline plus delamanid for XDR tuberculosis. Lancet Infect. Dis. 16, 294 (2016).
    • (2016) Lancet Infect. Dis. , vol.16 , pp. 294
    • Lachâtre, M.1
  • 79
    • 84942091323 scopus 로고    scopus 로고
    • Compassionate and optimum use of new tuberculosis drugs
    • Reed, C. et al. Compassionate and optimum use of new tuberculosis drugs. Lancet Infect. Dis. 15, 1131 (2015).
    • (2015) Lancet Infect. Dis. , vol.15 , pp. 1131
    • Reed, C.1
  • 80
    • 84966656965 scopus 로고    scopus 로고
    • Therapeutic drug monitoring in anti-tuberculosis treatment: A systematic review and meta-analysis
    • Mota, L. et al. Therapeutic drug monitoring in anti-tuberculosis treatment: a systematic review and meta-analysis. Int. J. Tuberc. Lung Dis. 20, 819-826 (2016).
    • (2016) Int. J. Tuberc. Lung Dis. , vol.20 , pp. 819-826
    • Mota, L.1
  • 81
    • 84925234402 scopus 로고    scopus 로고
    • Therapeutic drug monitoring: How to improve drug dosage and patient safety in tuberculosis treatment
    • Sotgiu, G. et al. Therapeutic drug monitoring: how to improve drug dosage and patient safety in tuberculosis treatment. Int. J. Infect. Dis. 32, 101-104 (2015).
    • (2015) Int. J. Infect. Dis. , vol.32 , pp. 101-104
    • Sotgiu, G.1
  • 82
    • 84990938502 scopus 로고    scopus 로고
    • Official American thoracic society/Centers for disease control and Prevention/Infectious diseases society of america clinical practice guidelines: Treatment of drug-susceptible tuberculosis
    • Nahid, P. et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. Clin Infect Dis. 63, e147-e195 (2016).
    • (2016) Clin Infect Dis. , vol.63 , pp. e147-e195
    • Nahid, P.1
  • 83
    • 84922192256 scopus 로고    scopus 로고
    • The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
    • Daskapan, A. et al. The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection. Eur. Respir. J. 45, 569-571 (2015).
    • (2015) Eur. Respir. J. , vol.45 , pp. 569-571
    • Daskapan, A.1
  • 84
    • 84890108607 scopus 로고    scopus 로고
    • Therapeutic drug management: Is it the future of multidrug-resistant tuberculosis treatment?
    • Srivastava, S., Peloquin, C. A., Sotgiu, G. & Migliori, G. B. Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Eur. Respir. J. 42, 1449-1453 (2013).
    • (2013) Eur. Respir. J. , vol.42 , pp. 1449-1453
    • Srivastava, S.1    Peloquin, C.A.2    Sotgiu, G.3    Migliori, G.B.4
  • 85
    • 84922200165 scopus 로고    scopus 로고
    • The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection
    • Esposito, S., Codecasa, L. R. & Centis, R. The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection. Eur. Respir. J. 45, 571-574 (2015).
    • (2015) Eur. Respir. J. , vol.45 , pp. 571-574
    • Esposito, S.1    Codecasa, L.R.2    Centis, R.3
  • 86
    • 84864518733 scopus 로고    scopus 로고
    • Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: Systematic review and meta-analysis
    • Sotgiu, G. et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur. Respir. J. 40, 1430-1442 (2012).
    • (2012) Eur. Respir. J. , vol.40 , pp. 1430-1442
    • Sotgiu, G.1
  • 87
    • 84962566015 scopus 로고    scopus 로고
    • Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers
    • Wallis, R. S. et al. Tuberculosis-advances in development of new drugs, treatment regimens, host-directed therapies, and biomarkers. Lancet Infect. Dis. 16, e34-e46 (2016).
    • (2016) Lancet Infect. Dis. , vol.16 , pp. e34-e46
    • Wallis, R.S.1
  • 88
    • 84875255319 scopus 로고    scopus 로고
    • Supporting TB clinicians managing difficult cases: The ERS/WHO consilium
    • Blasi, F., Dara, M., van der Werf, M. J. & Migliori, G. B. Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. Eur. Respir. J. 41, 491-494 (2013).
    • (2013) Eur. Respir. J. , vol.41 , pp. 491-494
    • Blasi, F.1    Dara, M.2    Van Der-Werf, M.J.3    Migliori, G.B.4
  • 90
    • 80051511348 scopus 로고    scopus 로고
    • TB and M/XDR-TB infection control in european TB reference centres: The achilles' heel?
    • Sotgiu, G. et al. TB and M/XDR-TB infection control in European TB reference centres: the Achilles' heel? Eur. Respir. J. 38, 1221-1223 (2011).
    • (2011) Eur. Respir. J. , vol.38 , pp. 1221-1223
    • Sotgiu, G.1
  • 91
    • 84860345846 scopus 로고    scopus 로고
    • TB and MDR/XDR-TB in european union and european economic area countries: Managed or mismanaged?
    • Migliori, G. B. et al. TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged? Eur. Respir. J. 39, 619-625 (2012).
    • (2012) Eur. Respir. J. , vol.39 , pp. 619-625
    • Migliori, G.B.1
  • 93
    • 0033581124 scopus 로고    scopus 로고
    • Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project
    • Dye, C., Scheele, S., Dolin, P., Pathania & Raviglione, M. C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 282, 677-686 (1999).
    • (1999) JAMA , vol.282 , pp. 677-686
    • Dye, C.1    Scheele, S.2    Dolin, P.3    Pathania4    Raviglione, M.C.5
  • 97
    • 84902064897 scopus 로고    scopus 로고
    • Childhood tuberculosis: A roadmap towards zero deaths
    • Marais, B. J. & Graham, S. M. Childhood tuberculosis: a roadmap towards zero deaths. J. Paediatr. Child Health 52, 258-261 (2016).
    • (2016) J. Paediatr. Child Health , vol.52 , pp. 258-261
    • Marais, B.J.1    Graham, S.M.2
  • 100
    • 84963682933 scopus 로고    scopus 로고
    • Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV
    • Den Boon, S., Matteelli, A., Ford, N. & Getahun, H. Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV. Aids 30, 797-801 (2016).
    • (2016) AIDS , vol.30 , pp. 797-801
    • Den Boon, S.1    Matteelli, A.2    Ford, N.3    Getahun, H.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.